Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RemiFemin

This article was originally published in The Tan Sheet

Executive Summary

GlaxoSmithKline's mass market launch of black cohosh supplement includes campaign offering women "freedom kit" with coupons, menopause symptom-tracking journal and quarterly health magazine. GSK also is partnering with Cedars-Sinai Integrative Medicine Medical Group and SusanLoveMd.com in an educational program that kicks off this month with a three-part Web chat series on women's health, menopause and herbals. GSK obtained North American marketing rights from German herbals firm Schaper & Brummer; RemiFemin has been sold for the past four years in U.S. health food stores by Enzymatic Therapy. Product is available in 60- and 120-counts, carrying SRPs of $20 and $35.29. TV spots, print ads in women's magazines broke in February; agency is Creative Advertising Solutions (New York)
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS092289

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel